This is a Phase 1, first-in-human (FIH), randomized, double-blind, placebo-controlled, parallel-group, single ascending dose (SAD) study to evaluate the safety…

Chemotherapy-induced Peripheral Neuropathy (CIPN)

~Estimated

~$10 – $8,750

AnHorn Medicines Co. Ltd.NCT07697560

The Role Of Great Toe Strength And Its Association With The Severity Of Symptoms Of Chemotherapy-Induced Peripheral Neuropathy (CIPN)

Great Toe Strength (GTS) is a potential clinical biomarker that has been associated with functional mobility and health; Additionally, GTS has been identified …

Chemotherapy-induced Peripheral Neuropathy (CIPN)Healthy

~Estimated

~$10 – $750

University of FloridaNCT07009717